Cleary Gottlieb is representing Barclays Capital Inc. as financial advisor to VCA Inc. in connection with the proposed acquisition of VCA by Mars, Incorporated, for $93.00 per share, representing an aggregate enterprise value of approximately $9.1 billion.
The transaction was announced on January 9, 2016, and is expected to close in the third quarter of 2017, subject to customary closing conditions, including receipt of required regulatory approvals and the approval of VCA’s stockholders.
VCA is one of the world’s largest and most diverse pet health care companies, operating nearly 800 animal hospitals with 60 diagnostic laboratories throughout the United States and Canada. Mars is a privately held American global manufacturer of confectionery, pet food and other food products.
VCA will be integrated into the Mars Petcare business, one of the world’s leading pet care providers, and will operate as a distinct and separate business unit within Mars Petcare, alongside Mars Petcare’s other Veterinary Services businesses, BANFIELD® Pet Hospital, BLUEPEARL® and PET PARTNERS™.